Nutralife Biosciences Inc
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutrace… Read more
Nutralife Biosciences Inc (NLBS) - Total Liabilities
Latest total liabilities as of September 2022: $8.35 Million USD
Based on the latest financial reports, Nutralife Biosciences Inc (NLBS) has total liabilities worth $8.35 Million USD as of September 2022.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nutralife Biosciences Inc - Total Liabilities Trend (2012–2021)
This chart illustrates how Nutralife Biosciences Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nutralife Biosciences Inc Competitors by Total Liabilities
The table below lists competitors of Nutralife Biosciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PTS Inc
PINK:PTSH
|
USA | $5.11K |
|
THROMBOGENICS
BE:TG4
|
Germany | €19.74 Million |
|
Jr Global Reit
KO:348950
|
Korea | ₩1.59 Trillion |
|
KST BETEILIG N (KSW.SG)
STU:KSW
|
Germany | €3.01 Million |
Liability Composition Analysis (2012–2021)
This chart breaks down Nutralife Biosciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -3.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nutralife Biosciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nutralife Biosciences Inc (2012–2021)
The table below shows the annual total liabilities of Nutralife Biosciences Inc from 2012 to 2021.
| Year | Total Liabilities | Change |
|---|---|---|
| 2021-12-31 | $5.56 Million | +26.29% |
| 2020-12-31 | $4.41 Million | +53.15% |
| 2019-12-31 | $2.88 Million | +183.39% |
| 2018-12-31 | $1.02 Million | +245.72% |
| 2017-12-31 | $293.61K | -88.95% |
| 2016-12-31 | $2.66 Million | +11.08% |
| 2015-12-31 | $2.39 Million | +84.66% |
| 2014-12-31 | $1.30 Million | +80.21% |
| 2013-12-31 | $718.63K | +72.75% |
| 2012-12-31 | $415.99K | -- |